When lung cancer cells undergo DNA damage after radiation exposure and emit certain signals, RBM17 may sense these signals, translocate into the nucleus, facilitate the entry of MSI2, and subsequently interact with ATR, activating ATR along with CHK1 and other downstream molecules. This evidence concerns the gene RBM17 and lung carcinoma.